The Evolving Use of Gemtuzumab Ozogamicin in Acute Myeloid Leukemia

被引：0
|
作者：
Walter, Roland B. [1 ,2 ,3 ,4 ]
机构：
[1] Univ Washington, Fred Hutchinson Canc Res Ctr, Sch Med, Div Clin Res, Seattle, WA 98195 USA
[2] Univ Washington, Sch Med, Div Hematol, Med, Seattle, WA 98195 USA
[3] Univ Washington, Sch Med, Dept Lab Med & Pathol, Seattle, WA 98195 USA
[4] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2021年 / 19卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：152 / 154
页数：3
相关论文
共 50 条
  • [21] Gemtuzumab ozogamicin in non-acute promyelocytic acute myeloid leukemia
    Huetter, Marie-Luise
    Schlenk, Richard F.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (10) : 1369 - 1380
  • [22] Efficacy and toxicity of gemtuzumab ozogamicin in patients with acute myeloid leukemia
    van der Heiden, PLJ
    Jedema, I
    Willemze, R
    Barge, RMY
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 76 (05) : 409 - 413
  • [23] Gemtuzumab ozogamicin in acute myeloid leukemia: past, present and future
    Gottardi, Michele
    Sperotto, Alessandra
    Di Rora, Andrea Ghelli Luserna
    Padella, Antonella
    Cangini, Delia
    Giannini, Maria B.
    Simonetti, Giorgia
    Martinelli, Giovanni
    Cerchione, Claudio
    MINERVA MEDICA, 2020, 111 (05) : 395 - 410
  • [24] Biomarkers of Gemtuzumab Ozogamicin Response for Acute Myeloid Leukemia Treatment
    Fenwarth, Laurene
    Fournier, Elise
    Cheok, Meyling
    Boyer, Thomas
    Gonzales, Fanny
    Castaigne, Sylvie
    Boissel, Nicolas
    Lambert, Juliette
    Dombret, Herve
    Preudhomme, Claude
    Duployez, Nicolas
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (16) : 1 - 21
  • [25] Mutational profile and benefit of gemtuzumab ozogamicin in acute myeloid leukemia
    Fournier, Elise
    Duployez, Nicolas
    Ducourneau, Benoit
    Raffoux, Emmanuel
    Turlure, Pascal
    Caillot, Denis
    Thomas, Xavier
    Marceau-Renaut, Alice
    Chantepie, Sylvain
    Malfuson, Jean-Valere
    Lemasle, Emilie
    Cheok, Meyling
    Celli-Lebras, Karine
    Guerin, Estelle
    Terre, Christine
    Lambert, Juliette
    Pautas, Cecile
    Dombret, Herve
    Castaigne, Sylvie
    Preudhomme, Claude
    Boissel, Nicolas
    BLOOD, 2020, 135 (08) : 542 - 546
  • [26] The role of Gemtuzumab Ozogamicin in the treatment of acute myeloid leukemia patients
    Pagano, L.
    Fianchi, L.
    Caira, M.
    Rutella, S.
    Leone, G.
    ONCOGENE, 2007, 26 (25) : 3679 - 3690
  • [27] Gemtuzumab ozogamicin in acute myeloid leukaemia
    Ravandi, Farhad
    Kantarjian, Hagop
    NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (06) : 310 - 311
  • [28] Gemtuzumab ozogamicin in acute myeloid leukaemia
    Farhad Ravandi
    Hagop Kantarjian
    Nature Reviews Clinical Oncology, 2012, 9 : 310 - 311
  • [29] The addition of gemtuzumab ozogamicin to chemotherapy in adult patients with acute myeloid leukemia
    Kell, Jonathan
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (04) : 377 - 382
  • [30] Gemtuzumab ozogamicin: A review of its use in acute myeloid leukaemia
    Fenton, C
    Perry, CM
    DRUGS, 2005, 65 (16) : 2405 - 2427
12345